Woman Man
- | Country :
- Ukraine
- Russian Federation
- Georgia
- | organs : -
- | Specialty : -
Extract
This is a Phase I, multi-centre, open-label, cross-over pharmacokinetic study designed to investigate whether the co-administration of a fixed dose of tesmilifene alters the plasma pharmacokinetics of a standard regimen of epirubicin and/or its principle metabolite, epirubicinol and cyclophosphamide.
Inclusion criteria
- Metastatic/Recurrent Breast Cancer